Fusion event
HBV-chr9 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCCTTGCCACAAGAACACATCATACAAAAAATCAAAGAATGTTTTAGAAAACTTCCTATTAACAGGCCTATTGATTGGAAAGTATGTCAACGAATTGTGG| |GTCTTTTGGGTTTTGCTGCCCCTTTTACACAATGTGGTTATCCTGCGTTGATGCCTTTGTATGCATGTATTCAATCTAAGCAGGCTTTCACTTTCTCGCC
End
45077550/61941398 (Hg38)
Nearest miRNA
hsa-mir-101-2/Upstream/20707563; hsa-let-7a-1/Downstream/8868577;
Upstream sequence
CAGCCCCGGCATTCCTGGAAAACAACCTTACAGACCAACTCAGGCTCCTGCTGCAGCCCCATGCTCTGTGCCCTCCCTGACTCTTGGGGCAGCTGTAAAG
Downstream sequence
GGGCTTCTAGGCTCTGTGGCTGGAGATTCGCGTCCAGGAGAACTCAGGTCCGAGGGTAGGCAGAGAAAAACAGTGTAAGAGTGCCAACAGAATGCTTTGA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.